Abciximab Before Direct Angioplasty and Stenting In
jurnal
Can newer antiplatelets replace clopidogrel
Patient Oriented Therapy Non STE ACS Prof dr Midhat nurkić FESC Director clinic for cardiovascular disease UKC Tuzla.
Preliminary Results A Multicenter Randomized Trial of Immediate Versus Delayed Invasive Strategy Immediate Versus Delayed Invasive Strategy in Patients.
Association Between Use of Bleeding Avoidance Strategies and Risk of Periprocedural Bleeding Among Patients Undergoing Percutaneous Coronary Intervention.
Statistical Considerations for Implementing the FDA CV Guidance for T2DM Craig Wilson, PhD NIC-ASA Fall Meeting October 15, 2009.
Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery G. Montalescot,
N Abciximab ER vs. Cath Lab, n=200 RELAx - MI Maioli & al. J Am Coll Cardiol 2007;49:1517–24.
cpr2010
STEMI/Stroke Guidelines for MS Barry Bertolet, MD Vice President MHCA November 8, 2014 1.
Standard Medical Therapy TRA 40 mg + 2.5 mg/d TRA 40 mg + 2.5 mg/d Placebo EP:CV Death/MI/stroke/hosp for RI/urgent coronary revasc. 1 EP:CV Death/MI/stroke/hosp.
